Development of the human gut microbiota commences at birth, with certain bifidobacterial species representing dominant and early colonisers of the newborn gastrointestinal tract. The molecular basis of Bifidobacterium colonisation, persistence and presumed communication with the host has remained obscure. We previously identified tight adherence (Tad) pili from Bifidobacterium breve UCC2003 as an essential colonisation factor. Here, we demonstrate that bifidobacterial Tad pili also promote in vivo colonic epithelial proliferation. A significant increase in cell proliferation was detectable 5 days postadministration of B. breve UCC2003. Using advanced functional genomic approaches, bacterial strains either (a) producing the Tad 2003 pili or (b) lacking the TadE or TadF pseudopilins were created. Analysis of the ability of these mutant strains to promote epithelial cell proliferation in vivo demonstrated that the pilin subunit, TadE, is the bifidobacterial molecule responsible for this proliferation response. These findings were confirmed in vitro using purified TadE protein. Our data imply that bifidobacterial Tad pili may contribute to the maturation of the naïve gut in early life through the production of a specific scaffold of extracellular protein structures, which stimulate growth of the neonatal mucosa.
Introduction
Colonisation of the neonatal gut has important trophic, metabolic and protective functions. Although the intestinal epithelium exhibits self-renewal kinetics from stem cells in the mucosa (Clevers, 2013) , the microbiota is an important environmental driver of the renewal of the intestinal epithelium, influencing mucosal morphology and homeostasis (Hooper, 2015) . Epithelial cell turnover in the colonised murine gut is about twice that of germ-free controls (Savage et al., 1981) . While some of the innate sensory pathways involved in bidirectional communication between the microbiota and the epithelium are known Hörmann et al., 2014) , the full molecular repertoire of signals from the microbiota to the epithelium is incompletely understood.
Signalling with the host may be a property common to many constituents of the microbiota, but we have focused on bifidobacteria for the following reasons. First, bifidobacteria are among the earliest colonisers of the neonatal gut and remain dominant until weaning. Second, comparative studies have shown that colonisation during early life when development and maturation is underway represents a critical window of opportunity where the microbiota can imprint host mucosal immunity and homeostasis . Thus, colonisation in later life does not confer the same developmental benefit as colonisation in the neonate . Third, increasing evidence suggests that the early life microbiota is a critical determinant of the risk of immune and metabolic diseases in later life (Shanahan, 2012; Gensollen and Blumberg, 2017) . Fourth, work from several research groups has demonstrated a diversity of bifidobacterial-derived protein and carbohydrate structures which elicit distinct host immune responses in the gut (Turroni et al., 2013; Ardita et al., 2014; Nishiyama et al., 2016; Schiavi et al., 2016; Tan et al., 2016; Ottman et al., 2017) .
Previously, we showed that bifidobacterial tight adherence pili (Tad pili) are required for in vivo colonisation . The Tad pilus fibre consists of multiple copies of one or more different pilin proteins, where the Flp pilin forms the pilin shaft which is decorated with pseudopilins, TadE and TadF. We now report that Tad pili also participate in microbe-host communication, specifically by delivering a proliferative signal to the host epithelium. We show Tad pilus-mediated epithelial proliferation is mediated by the TadE pseudopilin. Conservation of the tad gene cluster in all B. breve strains and all currently available Bifidobacterium genomes supports the concept of ubiquitous pili-mediated host-microbe signalling, and represents a step towards understanding the molecular detail of microbe-host dialogue in early life.
Results

B. breve UCC2003 Tad pili promote colonic epithelial proliferation
We previously established that B. breve UCC2003 Tad (designated here as Tad 2003 ) pili represent a colonisation factor in conventional animals that is specifically produced under in vivo conditions. We also determined using osmium tetroxide staining of intestinal sections, that B. breve UCC2003 is present in close proximity to the intestinal epithelia (Fig. 1) . The Tad 2003 gene cluster comprises genes encoding the pilin proteins, and the mechanisms required for the processing and assembly of the pilus structure ( Fig. 2A) . In order to establish if Tad 2003 pili have an effect on the host, 1 × 10 9 cells of B. breve UCC2003PK1 or a pilus-negative B. breve strain, UCC2003-tadAPK1 (O'Connell Motherway et al., 2011 , were administered by oral gavage to eight week old germ-free (GF) Swiss Webster mice (n = 7) for 5 days. Fecal samples were collected twice weekly for the ensuing three weeks to quantify bacterial shedding in the feces. Each strain monoassociated the GF mice to a similar level of 10 9 cfu g -1 of feces (Fig. 2B ). Animals were also weighed weekly, with no difference in weight change seen between the groups. At the end of the trial period samples of intestinal tissue were retained for immunohistochemistry analysis. As proliferating cells express Ki67 in their nuclei which can be detected by immunohistochemistry, sections were immunostained for Ki67 (Fig. 2C) , and the percentage of Ki67-positive cells per crypt enumerated (Fig. 2D) (Fig. 3B) , with full proliferation comparable to that found in the conventionalised animals observed within 5 days ( Fig 3C) . Although significance was lost at 9 days, the level of proliferation seen in the colon of mice monoassociated with B. breve UCC2003PK1 was greater than that of the GF controls ( Fig. 3D and Fig. S1 ). (Mierau and Kleerebezem, 2005) . A corresponding control strain, L. lactis NZ9000 pNZ8150-pPTPI, harbouring empty plasmids was also created. Pili production following nisin induction by L. lactis NZ9000 pNZ-tadZ-spkpPTPI-tadV was confirmed using immunogold electron microscopy ( Fig. 4A) immunohistochemical staining for both Ki67 (Fig. 5A ) and proliferating cell nuclear antigen (PCNA) ( Supplementary  Fig. S2A ), as both of these proteins are only detectable in the nuclei of proliferating cells. Quantification of cell proliferation demonstrated that mice monoassociated with B. breve UCC2003 or B. breve UCC2003 lacking TadF (UCC2003ΔtadF) showed similar levels of proliferation as seen in the conventional C57 black mouse controls.
( Fig. 5B and Supplementary Fig. S2B) . Intriguingly, the level of proliferation in the colonic epithelia of mice that had been monoassociated with B. breve UCC2003ΔtadE was similar to that of germ-free control animals ( Fig. 5B and Supplementary Fig. S2B ).
We next verified that the reduced level of proliferation seen in mice monoassociated with B. breve UCC2003ΔtadE was not due to the absence of pili production by this strain under in vivo conditions. Bacteria were recovered from the caecum of monoassociated animals, and the presence of Tad 2003 pili containing either TadE and/or TadF detected by immunogold electron microscopy ( Fig. 6A ). Pili containing both TadE and TadF were recovered from mice monoassociated with B. breve UCC2003 (Fig. 6A ). However, only pili containing TadF could be recovered from mice monoassociated with B. breve UCC2003ΔtadE (Fig. 6B) .
Finally, we confirmed the role of TadE in cell proliferation in vivo by reintroduction of the tadE gene in trans on plasmid pBC1.2, under the transcriptional control of the P44 promoter in the UCC2003ΔtadE mutant strain. GF mice were monoassociated with B. breve UCC2003, B. breve UCC2003 lacking TadE (UCC2003ΔtadE) or the complementation strain, designated UCC2003ΔtadE-pBC1.2-tadE. Intestinal tissue from these mice were immunostained for Ki67 (Fig. 7A ) or PCNA (Supplemental Fig. S2A ), and the level of proliferation enumerated ( Fig. 7B and Supplemental Fig. S2B ). The proliferative phenotype was restored in mice monoassociated with the complementation strain (Fig7 and Supplemental Fig. S2 ). We also confirmed by immunogold electron microscopy that the complementation strain produced pili containing both TadE and TadF (Supplemental Fig. S3 ). Collectively, these findings demonstrate that the pseudopilin TadE, but not TadF, promotes colonic epithelial cell proliferation and growth.
Purified TadE 2003 elicits epithelial proliferation under in vitro conditions
To confirm that TadE is crucial for the observed Tad TrxA-TadF or control TrxA, and cell proliferation determined by resazurin assay (Fig. 8A ). This concentration of protein was selected following stimulation of the cells with a serial dilution of the proteins. The TrxA-TadE fusion protein significantly increased cell proliferation in HT29 cells, comparable to the level of proliferation induced by epidermal growth factor, (EGF) (Fig. 8A ). In contrast, TrxA and TrxA-TadF failed to augment the proliferation of the cells (Fig. 8A ). We confirmed these findings using a BrdU incorporation assay ( Fig. 8B ). BrdU is a synthetic thymidine nucleoside that is incorporated into DNA by proliferating cells. Cells incubated with TrxA-TadE fusion protein showed significantly increased BrdU incorporation relative to control TrxA, consistent with the findings obtained by resazurin assay. Our preliminary investigations into the host receptor responsible for mediating this proliferative effect focussed on toll-like receptors (TLRs). The TLR family plays an important role in the detection of pathogens and commensals, responding to specific microbial ligands and to danger signals produced by the host during infection, as well as dampening responses to commensals and maintaining tissue homeostasis in physiologic conditions. TLRs are expressed by professional immune cells and by the large majority of non-hematopoietic cells, including epithelial cells. In humans, 10 TLRs have been identified to date and comprise both extracellular and intracellular receptors. In epithelial cells, constitutive and inducible expression of TLR2, TLR4 and TLR5 mRNA and protein has been shown in response to bacterial components and whole organisms. Given the important role played by TLRs in the intestine, we investigated whether the TadE proteins altered expression of the surface-expressed TLRs. However, no change in expression was detected (data not shown).
Discussion
We have identified the bifidobacterial-derived protein, TadE, as one of the signalling molecules within the microbiota which promote epithelial proliferation in the host. TadE is a constituent protein decorating the multimolecular pili on the surface of bifidobacteria. As with the other pilus proteins, TadE is not constitutively expressed in vitro and is evident only in vivo within the host. This is consistent with a specialised function and with a high degree of regulation. The proliferative effect on epithelial cells was, however, demonstrable and quantifiable on different epithelial cell lines in vitro when the tad 2003 cluster was expressed in L. lactis. Likewise, purified TadE elicits epithelial cell proliferation in vitro. Thus, the proliferative effect of TadE is a true signalling event and not solely attributable to another bifidobacterial effector molecule facilitated by pilus-mediated adhesion to the epithelia.
Since the microbiota may be a source of multiple distinct proliferative signals, the maximal level of epithelial proliferation must be constrained by strict host regulation. Indeed, it is noteworthy that the TadE-mediated epithelial proliferation was sufficient to mimic that seen in conventionally colonised animals, because the colonic epithelial proliferation evident in germ-free animals monoassociated with pilus-bearing B. breve UCC2003 was comparable with that of conventionally colonised mice. Other investigators have reported the morphological similarities of the intestinal mucosa of mono-associated experimental animals and that of fully colonised animals (reviewed in 17). In addition, exposure to an enteric virus has been reported to replace some of the beneficial functions of bacteria including reconstitution of mucosal architecture (Kernbauer et al., 2014) . Of course, mono-association studies must be interpreted with caution, results are strain-dependent, restoration of morphology does not imply full immunologic function and outcome may differ when compared with mice raised with a complex microbiota (Ericsson and Franklin, 2015) .
Although microbially induced epithelial proliferation is not exclusive to bifidobacteria, the TadE-mediated signal may have particular relevance in early life, because the Bifidobacteria are among the earliest and dominant colonisers of the neonatal gut. In this respect, it is noteworthy that we observed a significant increase in epithelial proliferation as early as 5 days postadministration of B. breve UCC2003. Moreover, it has been shown that the timing of colonisation is an important determinant of homeostasis in the host. Comparative analyses of animals colonised during development and at a later age have shown that colonisation at birth is required to optimally imprint the host's mucosal homeostasis .
Our preliminary investigations into the host receptor responsible for mediating this proliferative effect focussed on toll-like receptors (TLRs). The TLR family plays an important role in the detection of pathogens and commensals, responding to specific microbial ligands and to danger signals produced by the host during infection, as well as dampening responses to commensals and maintaining tissue homeostasis in physiologic conditions (McClure and Massari, 2014) . TLRs are expressed by professional immune cells and by the large majority of nonhematopoietic cells, including epithelial cells. In humans, 10 TLRs have been identified to date and comprise both extracellular and intracellular receptors. In epithelial cells, constitutive and inducible expression of TLR2, TLR4 and TLR5 mRNA and protein has been shown in response to bacterial components and whole organisms (McClure and Massari, 2014) . Given the important role played by TLRs in the intestine, we investigated whether the TadE protein altered expression of these surface-expressed TLRs. However, no change in expression was detected (data not shown).
Prospects for translating the TadE proliferative signal to a clinical arena have several challenges, but one of the clinical unmet needs for an agent such as this may be the immature mucosal barrier function of preterm infants, including susceptibility to necrotizing enterocolitis (NEC). NEC is the commonest gastrointestinal disease in low-weight premature neonates and is associated with high mortality rates. Clinical trials will be required to test whether the ability of TadE pili in promoting intestinal growth and maturation of the intestinal barrier can protect against pathogenic infection. Likewise, TadE might have application in mitigating the epithelial injury associated with nonsteroidal antiinflammatory drugs and cancer chemotherapy.
Several mechanisms by which bifidobacteria modulate host mucosal homeostasis in a strain-specific manner have previously been identified. Firstly, certain strains can exclude or inhibit pathogens, either through direct action or through modulation of the commensal microbiota. Secondly, epithelial barrier function may be enhanced by modulation of signalling pathways such as nuclear factor κB (NF-kB), Akt and mitogen-activated protein kinase (MAPK)-dependent pathways, which lead to the induction of mucus or increased tight junction functioning. Thirdly, many strains modulate host immune responses, exerting strain-specific local and systemic effects (Arumugam et al., 2011; Fanning et al., 2012; Konieczna et al., 2012) .
The role of pili in mediating adhesion and virulence of pathogens has been well studied in the intestine and urogenital tract using different organisms (Chessa et al., 2009; Arumugam et al., 2011; Wurpel et al., 2014) . More recently, the sortase-dependent pili encoded by Lb. rhamnosus GG and B. bifidum PRL2010 or type IV pili of A. muciniphila have also been shown to be essential for bacterial adhesion. (Ossowski et al., 2010; Turroni et al., 2013; Tytgat et al., 2016; Ottman et al., 2017) . While adhesion to the epithelium and colonisation may facilitate secondary host immune responses (Segers and Lebeer, 2014; Vargas García et al., 2015; Tytgat et al., 2016) , the present findings highlight the multifunctional nature of the multimolecular Tad pili of bifidobacteria in which adherence/colonisation and epithelial proliferative signalling are distinct molecular processes.
The full spectrum of Tad E signalling with the host epithelium and whether it could be deployed at extraintestinal sites remains to be established. Future work will address the Tad 2003 receptor distribution, on the one hand, and will identify the host-derived signals which influence the expression of Tad pili by bifidobacteria in vivo. Whether TadE has a role in microbe-microbe signalling is also an intriguing prospect. Although we have no experimental evidence to implicate TadE or Tad pili in any form of microbe-microbe interaction, it is known that bifidobacteria engage in microbial metabolic co-operation through cross-feeding strategies that allow resource sharing of available carbohydrates (Egan et al., 2014; Milani et al., 2015; O'Connell Motherway et al., 2018) .
In conclusion, the findings show that bifidobacteria, the predominant colonisers of the infant gastrointestinal tract, produce specific surface structures in response to in vivo conditions that are not only essential for efficient colonisation, but also promote intestinal proliferation, and thereby may influence early host development. The work may have therapeutic relevance to the management of preterm neonates in whom intestinal barrier function is immature.
Materials and methods
Bacterial strains and culture conditions
Bacterial strains used in this study are listed in Table 1 . Bifidobacterium breve UCC2003 was routinely cultured in reinforced clostridial medium (RCM; Oxoid Ltd, Basingstoke, Hampshire, UK) or in de Man Rogosa and Sharpe Medium (MRS) (De Man et al., 1960; Egan et al., 2014) prepared from first principles (O'Connell . Prior to inoculation the MRS was supplemented with cysteine-HCl (0.05%). Bifidobacterial cultures were incubated at 37°C under anaerobic conditions which were maintained using an anaerobic chamber (Davidson and Hardy, Belfast, Ireland). Escherichia coli was cultured in Luria Bertani broth (LB) (Sambrook et al., 1989) at 37°C with agitation. Lactococcus lactis strains were cultivated in M17 broth containing 0.5% glucose (Terzaghi and Sandine, 1975) ), respectively, and supplemented with X-gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside) (40 μg ml -1 ) and 1 mM IPTG (isopropyl-μ-D-galactopyranoside).
Nucleotide sequence analysis
Sequence data were obtained from the Artemismediated (Rutherford et al., 2000) genome annotations of the B. breve UCC2003 sequencing project . Database searches were performed using non-redundant sequences accessible at the National Centre for Biotechnology Information internet site (https://www.ncbi.nlm.nih.gov) using Blast. Sequence alignments were performed using the Clustal Method of the MEGALIGN program of the DNASTAR software package (DNASTAR, Madison, WI, USA).
DNA manipulations
Chromosomal DNA was isolated from B. breve UCC2003 as previously described (O'Riordan, 1998). Minipreparation of plasmid DNA from E. coli or L. lactis was achieved using the Qiaprep spin plasmid miniprep kit (Qiagen GmBH, Hilden, Germany) as described previously (O'Connell Motherway et al., 2009) . Singlestranded oligonucleotide primers used in this study were synthesised by Eurofins (Ebersberg, Germany). Standard PCRs were performed using TaqPCR mastermix (Qiagen), while high fidelity PCR was achieved using Q5 DNA polymerase (New England Biolabs, Darmstadt, Germany). B. breve colony PCRs were performed as described previously (O'Connell Motherway et al., 2009) . PCR fragments were purified using the Roche High pure PCR purification kit (Roche). Electroporation of plasmid DNA into E. coli was performed as described by Sambrook et al. (1989) and into L. lactis as described by Wells et al. (1993) . Electrotransformation of B. breve UCC2003 was performed as described by O'Connell Motherway et al. (2009) .
Plasmid constructions
For the construction of plasmid pNZ-tadZ-spk, DNA fragments encompassing the tadZ (Bbr_0132) to tadC (Bbr_0135), or flp (Bbr_0136) to spk (Bbr_0139) genes were generated by PCR amplification from chromosomal DNA of B. breve UCC2003 using Q5 DNA polymerase and primer combinations tadZF and tadCR, and flpF and spkR respectively. To facilitate translational fusion to the nisin promoter on pNZ8150 SmaI and XbaI or HindIII restriction sites were incorporated at the 5' ends of each forward and reverse primer combination respectively (Table S1 ). The two generated amplicons, TadZ-TadC or flp-spk, were digested with SmaI and XbaI or HindIII, and ligated into ScaI and XbaI or HindIII-digested nisin-inducible translational fusion plasmid pNZ8150 (Mierau and Kleerebezem, 2005) . The ligation mixtures were introduced into L. lactis NZ9000 (Table 1) by electrotransformation and transformants selected based on chloramphenicol resistance. The plasmid content of a number of Cm r transformants was screened by restriction analysis and the integrity of positively identified clones was verified by sequencing. To create the final construct pNZ-tadZ-spk, the pNis promoter plus the flp-spk fragment were amplified from pNZ-flp-spk using pNisF and spkR. The XbaI and HindIII restriction sites incorporated at the 5' ends of the forward and reverse primer combination facilitated cloning of the resultant fragment in the corresponding restriction sites of pNZ-tadZ-tadC.
The plasmid content of a number of Cm r transformants was screened by restriction analysis and the integrity of positively identified clones was verified by sequencing. The resulting construct was designated pNZ-tadZspk. For the construction of plasmid pPTPI-tadV a DNA fragment encompassing tadV (Bbr_0901) and its predicted Shine Dalgarno sequence were generated by PCR amplification from chromosomal DNA of B. breve UCC2003 using Q5 DNA polymerase and primer combinations tadVF and tadVR. AflIII and BamHI restriction endonuclease sequences incorporated in the forward and reverse primers, respectively, facilitated cloning in corresponding NcoI and BamHI sites of the nisin inducible transcriptional fusion vector pPTPI (O'Driscoll et al., 2004) . The ligation mixture was introduced into E. coli EC101 (Table 1) by electrotransformation and transformants selected based on tetracycline resistance. The plasmid content of a number of tet r transformants was et al. (1996) L. lactis NZ9000 pNZ-tadZ-tadC NZ9000 containing pNZ-tadZ-tadC This study L. lactis NZ9000-pNZ-flp-spk NZ9000 containing pNZ-flp-spk This study L. lactis NZ9000-pNZ-tadZ-spk NZ9000 containing pNZ-tadZ-spk This study L. lactis NZ9000-pPTPI-tadV NZ9000 containing pPTPI-tadV This study L. lactis NZ9000 pNZtrxA-tadE NZ9000 containing pNZtrxA-tadE This study L. lactis NZ9000 pNZtrxA-tadF NZ9000 containing pNZtrxA-tadF This study L. lactis NZ9000 pNZ-tadZ-spk-pPTPI-tadV NZ9000 containing pNZ-tadZ-spk and pPTPI-tadV et al. (2004) screened by restriction analysis and the integrity of positively identified clones was verified by sequencing. One verified plasmid designated pPTPI-tadV was introduced by electroporation into L. lactis NZ9000 pNZ-tadZ-spk to generate L. lactis NZ9000 pNZ-tadZ-spk-pPTPI-tadV.
Heterologous expression of Tad pili in L. lactis
To induce expression of Tad pili in L. lactis NZ9000 pNZtadZ-spk-pPTPI-tadV and compare to the control strain L. lactis NZ9000 harbouring the empty plasmids pNZ8150 and pPTPI 50 ml of M17 broth supplemented with 0.5% glucose was inoculated with a 2% inoculum of a particular L. lactis strain, followed by incubation at 30°C until an Optical Density (O.D. at wavelength 600 nm) of 0.5 was reached, at which point protein overexpression was induced by the addition of the cell-free supernatant of a nisin producing strain followed by continued incubation at 30°C for 90 min. Cells were harvested by centrifugation, washed and suspended in 50 ml of PBS. Enumeration of bacteria cells was performed by plate counting.
Cell lines and culture conditions
HT29, HCT116 and SW480 colonic epithelial cells were obtained from the American Type Culture Collection (Rockville, MD). Cells were maintained in DMEM containing 10% FCS and penicillin-streptomycin at 37 C with 5% CO 2 in a fully humidified atmosphere. Cells were seeded at 1 × 10 5 cells per millilitre unless otherwise stated and cultured overnight prior to use in the resazurin or brdU prolifearion assays.
Resazurin assay
Epithelial cells were seeded at 1 × 10 5 cells per millilitre in 6-well plates, cultured overnight, and then treated with 10 6 cfu of nisin-induced L. lactis NZ9000 pNZ8150, pPTPI, L. lactis NZ9000 pNZ-tadZ-spk-pPTPI-tadV for 8 h, or treated with purified TrxA, TrxA-TadE or TrxA- TadF (200ngml   -1 ). Cells were washed, media supplemented with 44 μM resazurin was added, and resazurin reduction to resorufin measured fluorometrically using a GENios plate reader (TECAN, Grodig, Austria) and Xfluor spreadsheet software. Results obtained were expressed in fluorescence units (FU) and the percentage viability calculated as follows: (FU-treated/FU control) × 100. Values were normalised relative to the untreated cells. ). 48h later, cell proliferation was measured through BrdU incorporation using the BrdU Cell Proliferation Assay Kit (Cell Signalling Technology, Beverly, MA), according to the manufacturers protocol.
BrdU proliferation assay
Cloning, overproduction and purification of the hydrophilic domains of TadE and TadF
For the construction of plasmids pNZtrxA-tadE and pNZtrxA-tadF DNA fragments encompassing the truncated tadE (from codon 61 to 127) and tadF genes (from codon 47 to codon 130) were generated by PCR amplification from chromosomal DNA of B. breve UCC2003 using Q5 DNA polymerase and primer combinations TadEHF and TadEHR, and TadFHF and TadFHR respectively. BamHI and XbaI restriction sites were incorporated at the 5' end of each forward and reverse primer combination respectively (Table S1 ). The generated amplicons were digested with BamHI and XbaI, and ligated into similarly digested nisin-inducible thioredoxin fusion plasmid pNZ-trxA (Douillard et al., 2011) . The ligation mixtures were introduced into L. lactis NZ9000 (Table 1) by electrotransformation and transformants selected based on chloramphenicol resistance. The plasmid content of a number of Cm r transformants was screened by restriction analysis and the integrity of positively identified clones was verified by sequencing. For protein overproduction and purification 400 ml of M17 broth supplemented with 0.5% glucose was inoculated with a 2% inoculum of a particular L. lactis strain, followed by incubation at 30°C until an Optical Density (O.D. at wavelength 600 nm) of 0.5 was reached, at which point protein overexpression was induced by the addition of the cell-free supernatant of a nisin producing strain, followed by continued incubation at 30°C for 90 min. Cells were harvested by centrifugation, washed and concentrated 40-fold in lysis buffer (50 mM NaH 2 PO 4 , 300 mM NaCl, 10 mM imidazole; pH 8.0). Cell extracts were prepared using 106 μm glass beads and the mini-bead-beater-8 cell disrupter (Biospec Products, Bartville, OK). After homogenisation the glass beads and cell debris were removed by centrifugation, while the supernatant containing the cytoplasmic fractions was retained. Protein purification from the cytoplasmic fraction was performed using Ni-NTA matrices in accordance with the manufacturers' instructions (Qiagen). Elution fractions were analysed by SDS polyacrylamide gel electrophoresis on a 12.5% polyacrylamide gel. After electrophoresis the gels were fixed and stained with Commassie Brilliant blue to identify fractions containing the purified protein. Rainbow prestained low molecular weight protein markers (New England Biolabs, Herdfordshire, UK) were used to estimate the molecular weight of the purified proteins. 
Construction of B. breve UCC2003ΔtadE or UCC2003ΔtadF deletion mutant strains
Isogenic non-polar deletion mutants of tadE (Bbr_0137), or tadF (Bbr_0138), with 276 bp of the 381 bp of tadE, or 327 bp of the 390 bp of tadF deleted, were created using pBS423Δrep constructs generated by the splicing by overlap extension (SOEing) PCR procedure (Horton et al., 1990) . In each case primers SOE AB and SOE CD (Table S1 ) were used to amplify regions flanking the sequence to be deleted using genomic DNA of B. breve UCC2003 as template. The resulting PCR products, designated I or II were purified, mixed in a 1:1 ratio and used as template with primers SOE EF. The resulting product was digested with Pst1 and ligated to similarly digested pBS423Δrep (Hirayama et al., 2012) prior to transformation into E. coli EC101 by electroporation. Transformants were selected based on resistance to Kn and Spec and screened by colony PCR using primers pBSF and pBSR to identify clones harbouring the correct insert. The presence of the correct insert in a number of positive clones was confirmed by plasmid isolation and restriction analysis, while the sequence integrity of the cloned DNA fragment, and the orientation of the insert in the pBS423Δrep vector was confirmed by sequencing. First crossover insertion mutations were generated essentially as described previously (O'Connell Motherway et al., 2009 ) to produce B. breve UCC2003 derivatives that were designated UCC2003-tadE-(I) or UCC2003-tadE-(II), or UCC2003-tadF-(I) or UCC2003-tadF-(II), respectively, where I or II indicate that the first crossover occurred via fragment I or II (described above). Site-specific recombination in potential spec-resistant mutant isolates was confirmed by colony PCR using primer combinations specFw and specRv to verify spectinomycin gene integration, and primers tadESOE A or tadF2SOE A (positioned upstream of the selected flanking regions of tadE 2003 or tadF 2003, respectively), each in combination with pBSR or to confirm integration at the correct chromosomal location. To promote pBS423Δrep plasmid excision in UCC2003-tadE-(I) or UCC2003-tadE-(II), or UCC2003-tadF-(I) or UCC2003-tadF-(II), plasmid pRTB101-CM was introduced into each strain and transformants were selected on RCA supplemented with CM. CM-resistant colonies were subcultured for eight transfers to promote loss of integrated pBS423Δrep. Cells which had excised pBS423Δrep and had either reverted to the wild-type genotype, or harboured a tadE or tadF deletion, were selected based on a Cm r and Spec s phenotype. Screening of Spec s colonies for UCC2003 derivatives harbouring tadE or tadF deletion was performed by colony PCR using primer pairs tadESOEA and tadE-SOEB or tadF2SOEA and tadF2SOEB, respectively, and sequencing of the PCR products to confirm the in frame deletion. Curing of pRTB101-CM from B. breve deletion mutant strains was performed by subculturing at 42°C for 8 transfers followed by plating on RCA and screening for CM sensitive strains by replica plating.
Complementation of UCC2003ΔtadE
A DNA fragment encompassing tadE 2003 (Bbr_0137) was generated by PCR amplification from B. breve UCC2003 chromosomal DNA using Q5 High-Fidelity Polymerase (New England BioLabs, Herefordshire, United Kingdom) and primer pairs: tadEpNZ44F and tadEpNZ44R. The resulting fragment was digested with AflIII and XbaI, and ligated to the similarly digested pNZ44. The ligation mixture was introduced into L. lactis NZ9000 by electrotransformation and transformants were then selected based on Cm resistance. The plasmid content of a number of Cm-resistant transformants was screened by restriction analysis. The integrity of the cloned insert of one of the recombinant plasmids, designated pNZ44-tadE, was confirmed by sequencing. The tadE-coding sequence, together with the constitutive p44 lactococcal promoter, specified by pNZ44, was amplified by PCR from pNZ44-tadE using Q5 High-Fidelity DNA polymerase and primer combination P44 Forward and tadEpNZ44R (Table S1 ). The resulting DNA fragment was digested with HindIII and XbaI, and ligated to the similarly digested pBC1.2. The ligation mixture was introduced into E. coli XL1-blue by electrotransformation and transformants selected based on Tet and Cm resistance. Transformants were checked for plasmid content using colony PCR, restriction analysis of plasmid DNA and verified by sequencing. pBC1.2-tadE was introduced into the deletion mutant B. breve UCC2003ΔtadE by electrotransformation and transformants were selected based Cm resistance. The resulting strain was designated B. breve UCC2003ΔtadE-pBC1.2-tadE.
Colonisation of germ-free mice
All experiments using mice were approved by the University College Cork animal ethics committee.
Eight-week-old female, germ-free C57Bl/6 or Swiss Webster mice were housed in flexible film gnotobiotic isolators under a strict 12 h of light cycle. Mice were fed an autoclaved standard polysaccharide-rich mouse chow diet. Mice (n = 7 or 16 per group) were inoculated with 1 × 10 9 cfu of a particular B. breve strain (UCC2003PK1, UCC2003-tadA, UCC2003ΔtadE, UCC2003ΔtadF or UCC2003ΔtadE-pBC1.2-tadE) in 20 μl of PBS by oral pipetting whereby the inoculums are delivered by positioning a micropipette tip immediately behind the incisors. Five mice were maintained as uninoculated controls to monitor the germ free status of the facility. Faecal pellets were collected twice weekly to determine the number of each strain present. At day 30, the animals were sacrificed and their intestinal tracts quickly dissected. Samples were retained for bacterial enumeration, immunohistochemistry analysis and immunogold electron microscopy analysis. To ensure that changing the murine strain did not impact the findings obtained, mice mono-associated with wildtype B. breve UCC2003 as well as GF animals were included as controls in all studies, with similar findings obtained.
Immunohistochemistry analysis
Immunohistochemical staining was performed on 4μM thick formalin-fixed, paraffin-embedded (FFPE) tissue sections. Sections were deparaffinised in xylene and rehydrated prior to analysis. Antigen retrieval was performed by microwave irradiation in 0.01 M citrate buffer, pH 6.0. Slides were washed twice for 5 min in a wash buffer containing 50 mM Tris-Cl, pH 7.6; 50 mM NaCl; 0.001% saponin. Endogenous peroxidase was quenched with 3.0% hydrogen peroxide in methanol for 10 min. Nonspecific binding was blocked using 5% normal serum in wash buffer for 1 h. Sections were incubated overnight at 4°C with anti-Ki67 primary Ab (Thermo Fisher Scientific, Fermont, CA), or with anti-PCNA primary antibody (Abcam, Cambridge, UK). Primary Ab binding was localised using a biotinylated secondary Ab, and visualised using avidin-conjugated HRP and diaminobenzidine (DAB) substrate, contained within the Vectastain avidin-biotin complex (ABC) detection kit (Vector Laboratories, Burlingame, CA). Slides were counterstained with hematoxylin. A parallel negative control was also performed, using rabbit IgG instead of the primary Ab. The number of Ki67-positive cells, or PCNA-positive cells per total number of cells within a crypt was enumerated by counting the number of Ki67-positive cells per crypt, with a minimum of 10 crypts per tissue section counted. The proliferative index is expressed as the percentage Ki67-positive cells, or percentage PCNA-positive cells per number of cells within a crypt. All immunohistochemical analysis and cell counting was performed in a blinded manner.
Immunogold and osmium tetroxide transmission electron microscopy (TEM) analysis
For the examination of B. breve cells recovered from the murine caecum, samples of 10 mg of caecal contents from animals monoassociated with either B. breve UCC2003, or UCC2003ΔtadE were suspended in 1 ml of fixative solution (0.5 M sucrose in 0.1 M Na-phosphate buffer, 2% paraformaldehyde and 0.16% glutaraldehyde) and fixed for 2 h at room temperature. Subsequently, the fixed caecal chyme underwent 3 low-speed centrifugation steps (100 rpm × 1 min) to remove particulate material, and the fixed bacterial cells in the supernatant were retained. For the examination of nisin-induced L. lactis cultures the bacterial cultures were diluted 1:5 in fixative solution and fixed for 2 h at room temperature. Thereafter, formvar-carbon-coated copper grids were floated on 100 μl droplets of the B. breve or L. lactis bacterial suspensions for 1 h, washed three times with 0.02 M glycine in PBS and blocked 15 min with 1% BSA in PBS. For the first labelling step, the grids were incubated for 1 h on a droplet of 1:50 diluted anti-TadE 2003 , washed four times for 2 min with 0.1% BSA in PBS, and incubated for 20 min with protein A conjugated to 5 nm gold particles diluted 1:55 in blocking solution. The grids were washed four times with PBS and fixed for 5 min with 1% glutaraldehyde, followed by 8 washes, each for 2 min, with distilled water. For the second labelling step the grids were incubated for 1 h on a droplet of 1:50 diluted anti-TadF 2003 , the same procedure was followed but this time adopting protein A conjugated to 10 nm gold particles diluted 1:55 in blocking solution. Finally, negative staining with a mixture of 1.8% methylcellulose-0.4% uranyl acetate was performed at 4 o C. The grids were examined, and micrographs visualised, using a JEM-1400 transmission electron microscope (JEOL Ltd., Tokyo, Japan). For osmium tetroxide staining, the intestinal tissue was washed once with 0.1 M phosphate buffer and fixed 2 h at RT with 2% glutaraldehyde in 0.1 M phosphate buffer. After fixation the sample was washed three times with 0.1 M phosphate buffer and postfixed with 1% osmiumtetroxide for 1 h at RT, dehydrated with graded series of ethanol, and incubated with transitional solvent acetone, after which the sample was gradually embedded in Epon and thin sectioned. The thin sections visualised using Jeol JEM-1400 transmission electron microscope.
Statistical analysis
Results are presented as mean ± SEM. Findings were statistically evaluated using one-way Anova with Dunnett's post-test. The p value, p < 0.001, p < 0.01 or p < 0.05 is indicated by three, two or one stars (*) respectively.
